Synapse Open Synapse
Biology

Big-name investors pour $100M into DNA therapeutics developer Seawolf

BioPharma Dive · · 2 min read

The startup, which also just disclosed an up to $1.2 billion partnership with Sanofi, is backed by Versant, MPM BioImpact, Eli Lilly and Novartis’ venture arm.

Latest from BioPharma Dive